Advemto

Advemto is a deep-tech photonics company that develops turnkey solutions for ultrafast spectroscopy, including its proprietary 2D molecular barcode reader, the MatriX-1. By converting fluorescent signals into sharp, distinct 2D barcodes, the technology enables labs to identify hundreds of biomarkers simultaneously, overcoming the limitations of traditional fluorescent labeling methods that often suffer from signal interference and restricted capacity. This innovation is designed to enhance precision, sensitivity, and speed in complex analysis across industries such as pharmaceuticals, clinical diagnostics, materials science, and energy.

The technology originated from research conducted in the Ultrafast Spectroscopy Lab at Te Herenga Waka Victoria University of Wellington and the MacDiarmid Institute. By providing a faster and more accurate alternative to existing instrumentation, Advemto aims to reduce the time and cost associated with iterative label panel design in drug development and clinical trials. Headquartered in Wellington, New Zealand, the company is backed by various institutional investors and focuses on accelerating next-generation research through its advanced analytical hardware systems.